Feyza Erenler MD
Endocrinology
Assistant Professor Associate Program Director
Join to View Full Profile
800 Washington StBoston, MA 02111
Phone+1 617-636-5689
Dr. Erenler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Feyza Erenler is an internal medicine specialist based in Boston, MA, with a subspecialty in endocrinology. She completed a fellowship in Endocrinology, Diabetes, and Metabolism at Tufts Medical Center in 2018 after graduating from Istanbul University Fom in 2011. Dr. Erenler has several publications, with notable works including research on hyperglycemia, pheochromocytoma, and glucocorticoid-induced hyperglycemia. Her research has been published in reputed journals such as the Journal of the American Pharmacists Association, Diabetes Care, and JAMA Network Open, with some studies cited multiple times by other publications.
Education & Training
Tufts Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2018
Istanbul University FomClass of 2011
Certifications & Licensure
MA State Medical License 2016 - 2027
OH State Medical License 2015 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Thyroid-Stimulating Hormone/Growth Hormone Cosecreting Pituitary Adenoma With Normal Thyroid-Stimulating Hormone Level.Feyza Erenler, Benjamin Katcher, Van Phan, Knarik Arkun, Mina G Safain
JCEM Case Reports. 2025-05-01 - Megestrol acetate as an overlooked cause of hyperglycemia in end-stage renal disease: A case of polypharmacyJohn Aurora Jr, Theresa Zheng, Julieta Rossi Fortunati, Feyza Erenler
Journal of the American Pharmacists Association. 2024-09-12 - 13 citationsType 2 Diabetes Polygenic Score Predicts the Risk of Glucocorticoid-Induced Hyperglycemia in Patients Without Diabetes.Aaron J Deutsch, Philip H Schroeder, Ravi Mandla, Sarah Kang, Feyza Erenler
Diabetes Care. 2023-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
